A clinical study of microneedle vaccination with influenza virus

A clinical study of microneedle vaccination with influenza virus - A clinical study of microneedle vaccination with influenza virus

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007502

Enrollment

Registered

2012-03-14

Start date

2011-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza

Interventions

microneedle vaccination with influenza hemmagglutinin conventional subcutaneous injection with influenza hemmagglutinin

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: heathy male 20-65 years old

Exclusion criteria

Exclusion criteria: female, people who had allergy for influenza vaccination, people who have fever on the day of administration

Design outcomes

Primary

Measure	Time frame
Elevation of serum IgG, IgA, IgM titer against influenza hemmagglutinin	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026